Dr Reddy’s Laboratories, an integrated global pharma company, announced
the launch of Melgain, lotion that has been approved for the treatment
of vitiligo, to benefit patients of the skin pigmentation disorder in
India. The medication has been launched in partnership with Issar
Pharmaceuticals to increase access to a novel treatment for vitiligo
patients in India.
lobally, Melgain lotion (decapeptide) is the first peptide-based drug for the treatment of vitiligo. It has been indigenously developed in India. Melgain lotion is the only patented decapeptide derived from basic fibroblast growth factor, a substance the body naturally produces for maintaining the structure and function of melanin producing cells. Melgain lotion is safe and efficacious in vitiligo cases involving various areas of the body, as established by a number of clinical studies. Its safety is well established for treating children as well.
lobally, Melgain lotion (decapeptide) is the first peptide-based drug for the treatment of vitiligo. It has been indigenously developed in India. Melgain lotion is the only patented decapeptide derived from basic fibroblast growth factor, a substance the body naturally produces for maintaining the structure and function of melanin producing cells. Melgain lotion is safe and efficacious in vitiligo cases involving various areas of the body, as established by a number of clinical studies. Its safety is well established for treating children as well.
No comments:
Post a Comment